The global dyslipidemia treatment market is experiencing significant growth in the coming years. This situation can be attributed to a growing prevalence of cardiovascular diseases, coupled with aging populations. The market is dominated by key players who are continuously innovating novel treatment options. Key segments within the dyslipidemia tr